
Eoflow Co Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Eoflow Co., Ltd. is a South Korean medical device company specializing in the development and production of wearable drug delivery systems, with a focus on insulin delivery for diabetes management. The company’s primary product is a compact, wearable insulin pump designed to provide continuous and precise insulin administration, supporting the needs of individuals with diabetes. Eoflow leverages advanced microfluidic and electrochemical technology to enhance device functionality and user convenience. The company is headquartered in Seongnam, South Korea, and its shares are listed on the KOSDAQ.
Latest articles
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
Ticker symbol
294090
Country
🇰🇷 South Korea